Dachaigh › Cairtean uaine › Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc.: sponsorachadh cairt uaine (PERM)
Chuir Constellation Pharmaceuticals, Inc. 3 iarrtasan dearbhaidh obrach PERM a chaidh a dhearbhadh ann am bliadhnaichean ionmhais 2024–2026; dearbhte: 0. Tuarastal meadhanach tairgte —; ùine mheadhanach bhon chur-a-steach chun dearbhadh: — làithean.
Tuarastalan H-1B aig Constellation Pharmaceuticals, Inc. →
Tiotalan dreuchd
| Tiotal dreuchd | Iarrtasan PERM | Tuarastal meadhanach |
|---|---|---|
| Clinical Operational Manager (“COMâ€) | 1 | — |
| Associate Director, CMC Analytical Development | 1 | — |
| Associate Director, Clinical Quality Assurance / GCP QA | 1 | — |
Làraich obrach
Gnìomhan
Co-dhùnaidhean as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Air a cho-dhùnadh | Inbhe | Làithean |
|---|---|---|---|---|---|---|
| Associate Director, Clinical Quality Assurance / GCP QA | $195,500–$200,000 | Boston, MA | 18 Iuch 2024 | 13 Lùna 2025 | Air a tharraing air ais | — |
| Associate Director, CMC Analytical Development | $175,000–$185,000 | Boston, MA | 29 Iuch 2024 | 10 Iuch 2025 | Air a tharraing air ais | — |
| Clinical Operational Manager (“COMâ€) | $133,000–$150,000 | Boston, MA | 17 Dàmh 2024 | 6 Faoi 2025 | Air a tharraing air ais | — |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; bidh na staitistigean a’ cleachdadh iarrtasan làn-ùine teisteanasach. Is e teisteanas PERM aon cheum a dh’ionnsaigh caird-uaine; bidh USCIS a’ co-dhùnadh an ath-thagraidh. Chan e comhairle laghail a th’ ann. Stòr: Roinn Obrach nan SA, Dàta Foillseachaidh OFLC PERM, bliadhnaichean ionmhais 2024–2026 (co-dhùnadh as ùire 30 Ògmh 2026).